Attitudes and Beliefs and the Steps of HIV Care
Through a prospective observational cohort study enrolling patients newly diagnosed with Human immunodeficiency virus (HIV):
Aim 1: Assess attitudes and beliefs about HIV disease and care over time and relate those attitudes and beliefs to success in following the Steps of HIV Care.
Aim 2: Validate a simple visual analogue scale for assessing adherence to highly active antiretroviral therapy (HAART) in patients newly starting HAART in routine care.
Aim 3: Implement latent growth curve analysis for modeling changes in attitudes and beliefs over time, and for assessing the impact of the components of the Steps of HIV Care model on health outcomes.
|Study Design:||Observational Model: Cohort
Time Perspective: Prospective
|Official Title:||Attitudes and Beliefs and the Steps of HIV Care|
- Survey to Assess Attitudes + Beliefs about Steps of HIV Disease Care [ Time Frame: Interviewer-administered at time of enrollment and every 3 months for 18 months ] [ Designated as safety issue: No ]
|Study Start Date:||April 2008|
|Study Completion Date:||November 2012|
|Primary Completion Date:||November 2012 (Final data collection date for primary outcome measure)|
HIV Care Questionnaire
Patients with a new diagnosis of HIV infection.
Questionnaire taking 60-90 minutes.
Other Name: Survey
The introduction of highly active antiretroviral therapy (HAART) dramatically improved the survival of patients with HIV in the US. The effectiveness of HAART in routine care is determined by the success with which patients are able to follow certain crucial Steps of HIV Care. This 'Steps of HIV Care' framework is based on the Centers for Disease Control and Prevention's (CDC's) "Serostatus Approach to Fighting the HIV Epidemic," which has been overlaid with patient and process of care factors. It includes 1) access outpatient care, 2) utilize care and treatment services, and 3) adhere to care, including medications and appointments.
|United States, Texas|
|Baylor College of Medicine|
|Houston, Texas, United States, 77030|
|Principal Investigator:||Michael A. Kallen, PhD||M.D. Anderson Cancer Center|